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iabetes develops if pancreatic -cells fail to
provide sufﬁcient amounts of insulin at a given
degree of insulin resistance. In type 1 diabetes,
the extent of -cell loss at the time of disease
onset has been estimated to be 60–70% (1,2), while
studies in patients with type 2 diabetes and individuals
with impaired fasting glucose have reported -cell deﬁcits
of 65 and 50%, respectively (3). However, while im-
paired islet cell mass and function seem to determine the
development of diabetes to a large extent, individual risk
undoubtedly also depends on other parameters, such as
obesity and insulin resistance (4).
Over the years, increasing evidence has accumulated
that shows that, in addition to these established risk
factors, low birth weight is also associated with a greater
risk of developing type 2 diabetes later in life (5,6). The
causes underlying this association have been debated, and
fetal malnutrition has been proposed as a potential mech-
anism (7,8).
Freathy et al. (9), as reported in this issue of Diabetes,
have now tested the alternative hypothesis (the fetal
insulin hypothesis) that genetic variants predisposing to
type 2 diabetes might also reduce birth weight by altering
intrauterine insulin secretion or action. Using fetal DNA
from 7,986 mothers and 19,200 offspring from four Euro-
pean studies, the authors provide convincing evidence for
a link between two recently identiﬁed type 2 diabetes loci
(CDKAL1 and HHEX-IDE) and reduced birth weight, with
a mean difference in birth weight of 80 g between carriers
of four type 2 diabetes risk alleles and individuals carrying
none of these risk alleles.
What are the common factors that confer coincident
risk of type 2 diabetes and low birth weight? Although
alterations in both insulin secretion and insulin action are
theoretically possible, a number of points seem to support
the hypothesis that impairments in early -cell develop-
ment lead to fetal malnutrition and predispose individuals
to development of type 2 diabetes later in life. Indeed,
-cell mass has been increasingly recognized as a central
cause of type 2 diabetes over the years (10). Thus, even
though obesity and insulin resistance clearly increase the
likelihood of developing diabetes (11), a substantial per-
centage of obese individuals remain free of diabetes
throughout life, and, in turn, pancreas transplantation has
been shown to restore normoglycemia even in insulin-
resistant patients with type 2 diabetes (12). The impor-
tance of -cell mass for individual type 2 diabetes risk has
been further highlighted by the results of recent genome-
wide scans that have uniformly linked the likelihood of
developing type 2 diabetes to genetic defects in insulin
secretion (13–15). In particular, the two loci that were
related to low birth weight in this study (CDKAL1 and
HHEX-IDE) have been shown to be associated with
signiﬁcant impairments in -cell function (16,17). There-
fore, the most likely explanation for the association be-
tween low birth weight and the risk for type 2 diabetes
seems to be a genetically determined maldevelopment of
-cells leading to insufﬁcient insulin secretion. The
intrauterine insulin deﬁciency may then impair fetal
growth (18), while insufﬁcient insulin secretion later in
life may confer an increased risk of developing type 2
diabetes. Consistent with such reasoning, autopsy stud-
ies in 46 children aged between 2 weeks and 21 years
have revealed a more than ﬁvefold variation in pancre-
atic -cell area between children of similar age (19).
Taken together, the ﬁndings of these and the recent
genetic studies indicate that pre- and postnatal malde-
velopment of islets leading to insufﬁcient insulin secre-
tion may be an important, yet underappreciated, risk
constellation for the subsequent manifestation of type 2
diabetes.
These studies suggest that we reconsider our current
thinking of the pathogenesis of type 2 diabetes; three
different concepts seem to emerge (Fig. 1A). The insulin
resistance concept proposes that islet -cells increase
their insulin secretion in response to declining peripheral
insulin action until a point of -cell exhaustion and man-
ifestation of hyperglycemia (20) (Fig. 1A). Based on this
hypothesis, insulin resistance triggers -cell failure
through an increased secretory demand. According to the
-cell apoptosis concept, -cell mass declines because
of an increased rate of -cell apoptosis (Fig. 1B) (3).
The loss of islet -cells leads to impairments in insulin
secretion, thereby promoting the manifestation of hy-
perglycemia. The islet malformation concept is based on
the association between the genetic risk for type 2
diabetes and low birth weight, suggesting a genetic
constellation associated with impaired islet -cell devel-
opment (Fig. 1C) (9). As a consequence, -cell mass fails
to expand and grow to a normal extent, which subse-
quently leads to impaired insulin secretion and manifes-
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DIABETES, VOL. 58, JUNE 2009 1255tation of hyperglycemia. In reality, the pathogenesis of
type 2 diabetes likely involves a combination of these
three mechanisms, with the respective importance of
each pathway varying substantially between different
individuals.
Taken together, the fetal insulin hypothesis has pro-
vided a strong link between genetic -cell defects, low
birth weight, and the risk of type 2 diabetes. Accordingly,
the deﬁcit in -cell mass typically found in patients with
type 2 diabetes may not only be secondary to an increased
rate of apoptosis but may also be the consequence of
abnormal islet cell development and growth. The ﬁndings
by Freathy et al. (9) therefore signiﬁcantly extend our
knowledge on the pathogenesis of type 2 diabetes and will
certainly foster future work aiming to explore the role of
islet maldevelopment in the development of diabetes.
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FIG. 1. Three hypotheses for the pathogenesis of type 2 diabetes. A:
The insulin resistance concept proposes that islet -cells increase their
insulin secretion in response to declining peripheral insulin action
until a point of -cell exhaustion and manifestation of hyperglycemia.
B: The -cell apoptosis concept suggests that -cell mass declines
because of an increased rate of -cell apoptosis, thereby leading to
impairments in insulin secretion (3). C: The islet malformation concept
suggests a genetic constellation associated with impaired islet -cell
development. As a consequence, -cell mass fails to grow to a normal
extent, thereby leading to impaired insulin secretion.
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